Fundz

COSCIENS Biopharma

Toronto, Ontario, Canada · Biotechnology, Healthcare, Health Care

COSCIENS Biopharma Inc. (NASDAQ: CSCI) is a life science company specializing in developing cosmeceutical, nutraceutical, and pharmaceutical products. They aim to enhance health and wellness through innovative natural-based solutions. The company focuses on leveraging its portfolio and technologies for significant innovation and market growth.

Key facts

Headquarters
Toronto, Ontario, Canada
Employees
11
Industries
Biotechnology, Healthcare, Health Care
Status
Public (CSCIF)
Website
www.cosciensbio.com
LinkedIn
Company page

Recent activity at COSCIENS Biopharma

COSCIENS Biopharma funding history

DateRoundAmount
Oct 2019Seed$5.0M

Leadership

  • Brent Norton, Director
  • Gerard Limoges, Director
  • Robin Hoke, Director
  • Carolyn Egbert, Director
  • Anna Biehn, Chief Executive Officer
  • Nicola Ammer, Executive Officer
  • Klaus Paulini, Executive Officer
  • Leslie Auld, Executive Officer
  • Michael Ward, Executive Officer

Verified email and direct lines for COSCIENS Biopharma’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.

COSCIENS Biopharma in the news

Companies similar to COSCIENS Biopharma

About COSCIENS Biopharma: questions and answers

What does COSCIENS Biopharma do?

COSCIENS Biopharma Inc. (NASDAQ: CSCI) is a life science company specializing in developing cosmeceutical, nutraceutical, and pharmaceutical products. They aim to enhance health and wellness through innovative natural-based solutions. The company focuses on leveraging its portfolio and technologies for significant innovation and market growth.

Where is COSCIENS Biopharma headquartered?

COSCIENS Biopharma is headquartered in Toronto, Ontario, Canada.

How many employees does COSCIENS Biopharma have?

COSCIENS Biopharma has about 11 employees.

Has COSCIENS Biopharma raised funding?

Yes. Fundz has recorded 1 funding event for COSCIENS Biopharma. The most recent, Seed of $5.0M, was in Oct 2019.

Who leads COSCIENS Biopharma?

Anna Biehn is a Chief Executive Officer at COSCIENS Biopharma.

What is the latest news on COSCIENS Biopharma?

On Apr 14, 2025, COSCIENS Biopharma Appoints Anna Biehn as Chief Executive Officer

Is COSCIENS Biopharma a public company?

Yes. COSCIENS Biopharma is publicly traded under the ticker CSCIF.

Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy

Fundz watches COSCIENS Biopharma across 18 signal types, from funding and M&A to exec moves and hiring.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.